|
|
 |
|
Viewing report
|
|
|
|
Achieving Market Dominance Through Reformulation: A Strategic Insight
Business Insights, Aug 2001
More than $165bn in ethical revenues may be cannibalised as a consequence of patent expiry from 31 leading drug patent expirations between 2000 and 2005. In view of this, pharmaceutical reformulation represents a viable option to maintain market leadership for key drugs. Achieving Market Dominance Through Reformulation: A strategic insight, provides a detailed analysis of the drug reformulation arena with emphasis on achieving and sustaining market dominance for new formulations through co-development and marketing. The report will help you develop a focused, well-planned reformulation strategy involving R&D, investment, partnering, and marketing that is crucial for long-term commercial reformulation success.
Customers who bought this item also bought
Maximizing Product Returns Through Reformulation: Old Molecules, New Opportunities
Reformulation Strategies - Comparisons of Past and Future Reformulation Strategies
Commercial Insight: Osteoporosis - Risk management and reformulation offer best defense against generic onslaught
Market Dynamics: Antipsychotics - A Market Driven by Reformulation
The Rationale Behind Drug Reformulation: Five Case Studies and Overview of CNS Market and R&D
Lifecycle Management Strategies: Maximizing ROI through Indication Expansion, Reformulation and Rx-to-OTC Switching
Antihormonal Therapy Cancer Brands - Careful Lifecycle Management Needed to Preserve Brand Dominance
Antidyslipidemics - Cholesterol Absorption of Lipitors Dominance
Achieving the Triple Play: Technologies and Business Models for Success
Market Dynamics 2000: Migraine - Dominance of Triptans in the Global Market
Health Fairs: Planning, Marketing and Achieving Bottom-Line Results, Audio Conference on CD-ROM
Commercial Insight: Depression - Atypical lifecycle management strategy rejuvenates depression market
|
|
|
|
